SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Tech Devices 2023: The Most blazing Arrivals of the Year - 2Meet the Artemis crew in NASA's first astronaut mission to the moon in more than a half-century
- 3Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
- 4People who talk with their hands seem more clear and persuasive – new research
- 56 Arranging Administrations to Change Your Open air Space
- Instructions to Pick the Right Dental Expert for Teeth Substitution
- Ancient Egyptian pharaoh's boat is being reassembled in public at the Grand Egyptian Museum
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- Doggie diversity in size and shape began at least 11,000 years ago
- Clones of Stumpy, Washington D.C.'s beloved cherry blossom tree, have flowered for the first time
- The Manual for Electric Vehicles that will be hot merchants in 2023
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Germany's Merz under fire in Brazil for his comments on Amazon host city of COP30
